Skip to main content
logo
Faron Pharmaceuticals Oy (AIM:FARN)
London flag London · Delayed Price · Currency is GBP · Price in GBX
37.15
-0.85 (-2.24%)
Sep 4, 2026, 3:47 PM GMT

Faron Pharmaceuticals Oy Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-19.46-20.27-18.67-28.57-27.43-21.11
Net Income
-16.34-27.26-25.92-30.94-28.73-21.19
Earnings Per Share
-0.12-0.24-0.29-0.48-0.52-0.42
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
31.9812.329.56.886.996.85
Total Debt
17.9224.6812.1113.1113.273.55
Net Cash (Debt)
14.06-12.36-2.61-6.24-6.283.31
Net Cash Growth
-----274.41%
Net Cash Per Share
0.10-0.11-0.03-0.10-0.110.07

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-20.13-17.92-22.3-23.81-22.99-22.22
Capital Expenditures
---0---0.01
Free Cash Flow
-20.13-17.92-22.31-23.81-22.99-22.23
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------